OTC Antiviral Agents For Herpes Cold Sores Disfavored By FDA
This article was originally published in The Tan Sheet
Executive Summary
The future of potential OTC antiviral treatments for herpes labialis, including Avanir Pharmaceuticals' docosanol 10% cream, is questionable in light of FDA's announcement that it disfavors use of such antiviral drugs in a nonprescription setting.
You may also be interested in...
GSK, Galpharm Pioneer UK Nonprescription Omeprazole Market
Galpharm Healthcare will launch a nonprescription omeprazole product under the name Galpharm Heartburn Relief in the UK "shortly," according to a spokesperson for the British firm
GSK, Galpharm Pioneer UK Nonprescription Omeprazole Market
Galpharm Healthcare will launch a nonprescription omeprazole product under the name Galpharm Heartburn Relief in the UK "shortly," according to a spokesperson for the British firm
GSK, Galpharm Pioneer UK Nonprescription Omeprazole Market
Galpharm Healthcare will launch a nonprescription omeprazole product under the name Galpharm Heartburn Relief in the UK "shortly," according to a spokesperson for the British firm